Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lifestyle Interventions in Overweight and Obese Postpartum Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03826394
Recruitment Status : Recruiting
First Posted : February 1, 2019
Last Update Posted : August 22, 2019
Sponsor:
Information provided by (Responsible Party):
Stephanie Hanley, Nottingham Trent University

Brief Summary:
The current study aims to investigate the effects of a chosen technology-based exercise or healthy eating intervention that combines individual and group-based support, on weight loss and other health-related parameters in postpartum women with overweight or obesity. All participants will be asked to engage in a 20-week programme consisting of a 4 week tracked free living period followed by a 16-week intervention. The investigators hypothesise that reductions in BMI (body mass index) and improvements in health-related parameters will be observed post-intervention.

Condition or disease Intervention/treatment Phase
Overweight and Obesity Behavioral: Exercise Intervention Behavioral: Dietary Intervention Not Applicable

Detailed Description:

The current study will investigate the effects of a chosen exercise or dietary intervention on BMI and other health-related parameters in postpartum women with overweight and obesity. Dietary or physical activity interventions, alone or combined, are associated with greater weight loss when provided to women in the postpartum period, compared with no intervention. Providing a combined physical activity and dietary intervention is associated with an average weight loss of 2.49kg post-intervention and 2.4kg 12 months after pregnancy. However, the variation in average weight loss achieved is great which could be due to differences in the design of lifestyle programmes.

Interventions including individualised support and self-monitoring have proven more effective in promoting reductions in BMI in postpartum women. However, high levels of attrition and poor engagement have been highlighted as two areas that require attention in this area. Therefore, future research is required to identify strategies best suited to the design and implementation of effective lifestyle interventions in overweight and obese postpartum women.

Women between six weeks and one year postpartum will elect to be part of either a 16-week exercise or dietary intervention. Prior to this, participants will be tracked for a period of four weeks in free living conditions. Each intervention will be split into four blocks of three weeks where staged intervention specific information will be provided. Individualised face-to-face and technological group support will be provided throughout. For the final four weeks of the intervention no new information will be provided and all support will be withdrawn.

Analyses of body composition and girths, blood metabolites, resting heart rate, blood pressure, and questionnaires assessing physical activity, eating behaviours and quality of life will be carried out alongside assessments of BMI at baseline, pre-intervention and at both twelve and sixteen weeks of the intervention. Measures of BMI, resting heart rate, blood pressure and questionnaire scores will be taken at each three weekly stage of the intervention.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 42 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

Participants will take part in an exercise or dietary intervention in a non-randomised, parallel study.

Each intervention will be preceded by a four week tracked free-living period. Both interventions will be completed over a sixteen week period. Following the tracked period, participants will choose to take part in either the exercise or dietary intervention. Intervention information will be delivered in four, three week blocks. No new information will be provided during the final four weeks of the intervention.

Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Effects of Exercise and Dietary Interventions in Overweight and Obese Postpartum Women on Weight Management and Health.
Actual Study Start Date : August 19, 2019
Estimated Primary Completion Date : February 2020
Estimated Study Completion Date : February 2020

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Exercise Intervention
Exercise intervention with the aim of incrementally increasing physical activity to meet the national recommendation of 150 minutes a week of moderate-vigorous physical activity, reducing BMI and improving overall health.
Behavioral: Exercise Intervention
Education based sixteen week intervention where participants will be provided with core information every three weeks and supplementary information through technological means at other time points. All provided information will be exercise specific. Individualised and group support provided throughout the first twelve weeks and withdrawn for the final four weeks. Fitbit Flex 2 provided for the duration of the study.
Other Name: Physical Activity Intervention

Experimental: Dietary Intervention
Staged dietary intervention with the aim of improving eating behaviours, reducing BMI and improving overall health.
Behavioral: Dietary Intervention
Education based sixteen week intervention where participants will be provided with core information every three weeks and supplementary information through technological means at other time points. All provided information will be diet specific. Individualised and group support provided throughout the first twelve weeks and withdrawn for the final four weeks. Fitbit Flex 2 provided for the duration of the study.
Other Name: Nutritional Intervention/Healthy eating Intervention




Primary Outcome Measures :
  1. Changes in BMI [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]
    Weight (kg) and height (m) will be combined to report BMI in kg/m^2


Secondary Outcome Measures :
  1. Change in Body Composition [ Time Frame: Week 0, 4, 16, 20 ]
    Whole body DXA (dual energy X-ray absorptiometry) scan to assess fat mass, fat-free mass, bone density.

  2. Change in Blood Metabolites [ Time Frame: Week 0, 4, 16, 20 ]
    Fingertip blood sample taken to assess total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, glycated haemoglobin, random glucose.

  3. Change in Body Girths [ Time Frame: Week 0, 4, 16, 20 ]
    Measures (in cm) of waist, hip, thigh, calf, bust and upper arm girths.

  4. Change in Blood Pressure [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]
    Measure of blood pressure taken at rest.

  5. Change in Resting Heart Rate [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]
    Measure of heart rate taken at rest.

  6. Change in Quality of Life [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]

    Assessment of quality of life using the Impact of Weight on Quality on Life (Lite) and Short-Form 36 Questionnaires.

    Short-Form 36- scores range from 0-100 (lower scores= more disability; higher scores = less disability).

    Impact of Weight on Quality of Life- 31-item that calculates a total score and scores on 5 separate domains (physical function, self-esteem, sexual life, public distress, work).


  7. Change in Sleep Quality [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]
    Assessment of sleep quality using Pittsburgh Sleep Quality Index Questionnaire. Index contains 19 self-rated questions and 5 questions rated by the bed partner or roommate. Only self-rated questions are included in the scoring. Self-rated items are combined to form 7 component scores, each of which has a range of 0-3 points. A score of 0 indicates no difficulty while a score of 3 indicates severe difficulty. The 7 components scores are then summed together to yield one global score, with a range of 0-21 points. 0 indicates no difficulty and 21 indicates severe difficulties in all areas.

  8. Change in Eating Behaviours [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]
    Assessment of eating behaviours using Three Factor Eating Questionnaire. Responses to each of the 18 items are given a score of between 1 and 4 and item scores are summated into scale scores for cognitive restraint, uncontrolled eating and emotional eating. Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating.

  9. Change in Physical Activity Levels [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]
    Measures of physical activity levels through direct (Fitbit) and indirect (Godin 7-day leisure time physical activity questionnaire) measures.

  10. Change in Markers of Postnatal Depression [ Time Frame: Week 0, 4, 7, 10, 13, 16, 20 ]
    Assessment of markers of depression using Edinburgh Postnatal Depression Scale. Responses to each of the 10 items are given a score of 0 to 3. The maximum score is 30. Higher scores indicate greater degrees of depression, with a score of 13 or above indicating varying degrees of depressive illness.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Be at least 18 years old at the date of their first visit. Have a body mass index (BMI) of greater than 25 kg∙m2 (this will be worked out by the researchers using the participant's height and body weight). Have had a singleton pregnancy. Have had one pregnancy to date. Be 6 weeks-1 year postpartum (and had physician's approval to return to exercise).

Own a smartphone (able to download and use WhatsApp). In the researcher's opinion, the participant is able and willing to follow all trial requirements.

Exclusion Criteria:

Have a clinical diagnosis of depression/postnatal depression. Currently enrolled on another weight loss programme. Currently consuming weight loss tablets/supplements. Have heart/liver/chronic renal disease. Have a clinical diagnosis of Type 2 Diabetes Mellitus. Consume excessive amounts of alcohol (regularly drinking more than 14 units of alcohol a week). Actively trying for another baby/planning a pregnancy in the next 6 months. Experienced a stillbirth. Have any health conditions that affect physical activity engagement. On any medication that affects the ability to exercise. On any medication that affects the ability to follow a healthy eating programme.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03826394


Contacts
Layout table for location contacts
Contact: Stephanie J Hanley, MRes 07414542237 stephanie.hanley2016@my.ntu.ac.uk
Contact: Kirsty J Elliott-Sale, PhD 01158486338 kirsty.elliottsale@ntu.ac.uk

Locations
Layout table for location information
United Kingdom
Nottingham Trent University, Clifton Campus Recruiting
Nottingham, Nottinghamshire, United Kingdom, NG11 6AP
Contact: Stephanie Hanley    +447414542237    stephaniejanehanley@hotmail.com   
Sponsors and Collaborators
Nottingham Trent University
Investigators
Layout table for investigator information
Principal Investigator: Stephanie J Hanley, MRes Nottingham Trent University

Publications:
Layout table for additonal information
Responsible Party: Stephanie Hanley, Miss, Nottingham Trent University
ClinicalTrials.gov Identifier: NCT03826394     History of Changes
Other Study ID Numbers: NottinghamTU
First Posted: February 1, 2019    Key Record Dates
Last Update Posted: August 22, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Individual participant data may be made available to other researchers following completion of the current trial in an anonymised/pseudonymised format to prevent individual participant identification. Data will be provided in response to certain requests (e.g. if a systematic review and meta-analysis/statistical power calculation is being conducted that requires access to certain raw data).

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Stephanie Hanley, Nottingham Trent University:
Postpartum, Overweight, Obesity, Exercise, Diet, Lifestyle
Additional relevant MeSH terms:
Layout table for MeSH terms
Overweight
Body Weight
Signs and Symptoms